Regulatory T Cells Reduce Acute Lung Injury Fibroproliferation by Decreasing Fibrocyte Recruitment
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Acute lung injury (ALI) causes significant morbidity and mortality. Fibroproliferation in ALI results in worse outcomes, but the mechanisms governing fibroproliferation remain poorly understood. Regulatory T cells (Tregs) are important in lung injury resolution. Their role in fibroproliferation is unknown. We sought to identify the role of Tregs in ALI fibroproliferation, using a murine model of lung injury. Wild-type (WT) and lymphocyte-deficient Rag-1−/− mice received intratracheal LPS. Fibroproliferation was characterized by histology and the measurement of lung collagen. Lung fibrocytes were measured by flow cytometry. To dissect the role of Tregs in fibroproliferation, Rag-1−/− mice received CD4+CD25+ (Tregs) or CD4+CD25− Tcells (non-Tregs) at the time of LPS injury. To define the role of the chemokine (C-X-C motif) ligand 12 (CXCL12)–CXCR4 pathway in ALI fibroproliferation, Rag-1−/− mice were treated with the CXCR4 antagonist AMD3100 to block fibrocyte recruitment. WT and Rag-1−/− mice demonstrated significant collagen deposition on Day 3 after LPS. WT mice exhibited the clearance of collagen, but Rag-1−/− mice developed persistent fibrosis. This fibrosis was mediated by the sustained epithelial expression of CXCL12 (or stromal cell-derived factor 1 [SDF-1]) that led to increased fibrocyte recruitment. The adoptive transfer of Tregs resolved fibroproliferation by decreasing CXCL12 expression and subsequent fibrocyte recruitment. Blockade of the CXCL12–CXCR4 axis with AMD3100 also decreased lung fibrocytes and fibroproliferation. These results indicate a central role for Tregs in the resolution of ALI fibroproliferation by reducing fibrocyte recruitment along the CXCL12–CXCR4 axis. A dissection of the role of Tregs in ALI fibroproliferation may inform the design of new therapeutic tools for patients with ALI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“data from an LPS model of lung injury showing that Tregs suppress fibrocyte recruitment and fibrosis via interruption of the chemokine C-X-C motif ligand 4/stromal cell-derived factor 1 (CXCL4/SDF1) axis (156)”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [156]
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421801 · Cited by 12,941
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,923
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Incidence and Outcomes of Acute Lung Injury
Rubenfeld, G. D., Caldwell, E., Peabody, E., Weaver, J., Martin, D. P., Neff, M., Stern, E. J., & Hudson, L. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050333 · Cited by 3,684 · cited 2×
“Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) affect 190,000 individuals in the United States each year, accounting for 75,000 deaths (1).”
BackgroundMatute-Bello, G., Downey, G., Moore, B. B., Groshong, S. D., Matthay, M. A., Slutsky, A. S., & Kuebler, W. M. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0210st · Cited by 1,988
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079 · cited 5×
“CXCL12 (or stromal cell-derived factor 1 [SDF-1]) is the most potent ligand for the CXCR4 receptor (expressed on fibrocytes), and is an important stimulus for fibrocyte recruitment to the lung after injury (12).”
BackgroundResultInfluentialPulmonary fibrosis: pathogenesis, etiology and regulation
Wilson, M. S., & Wynn, T. A. (2009) · Mucosal Immunology · doi:10.1038/mi.2008.85 · Cited by 822 · cited 1×
“Because the fibroproliferative phase of ARDS is characterized by persistent interstitial inflammation (4), Tregs might be expected to reduce fibroproliferation, perhaps by dampening the inflammation that leads to myofibroblast accumulation and collagen deposition (31).”
BackgroundHas Mortality from Acute Respiratory Distress Syndrome Decreased over Time?: A Systematic Review
Phua, J., Badia, J. R., Adhikari, N. K. J., Friedrich, J. O., Fowler, R. A., Singh, J. M., Scales, D. C., Stather, D. R., Li, A., Jones, A., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200805-722oc · Cited by 727 · cited 2×
“Mortality from ALI/ARDS remains ashigh as 44%(3).”
BackgroundBone marrow–derived progenitor cells in pulmonary fibrosis
Hashimoto, N., Jin, H., Liu, T., Chensue, S. W., & Phan, S. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18847 · Cited by 720 · cited 2×
“In a model of bleomycin fibrosis, fibrocytes accounted for 20% of myofibroblasts (10, 15).”
Background
Cited by
Items 101–182 of 182
Liu, X., Jiang, S., Zhang, Q., Xu, S., Bao, X., Cao, W., Bai, J., & Tang, L. (2017) · Shock · doi:10.1097/shk.0000000000001070 · Cited by 24
Zhu, G., Liu, Y., Zhang, W., Huang, Y. X., & Li, K. (2018) · Immunologic Research · doi:10.1007/s12026-017-8983-2 · Cited by 22
The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis
Zhang, P., Wang, J., Miao, J., & Zhu, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1560578 · Cited by 29
Panagiotidis, G., Vásquez‐Pacheco, E., Chu, X., Seeger, W., Agha, E. E., Bellusci, S., & Lingampally, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609509 · Cited by 25
Dai, X., Yang, Z., Zhang, W., Liu, S., Zhao, Q., Liu, T., Chen, L., Li, L., Wang, Y., & Shao, R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.959010 · Cited by 19
“Studies have shown that Tregs can also reduce fibroblast aggregation and reduce the degree of pulmonary fibrosis by inhibiting fibroblast-9 and chemokine ligand 12 (51, 52).”
BackgroundAge-Dependent Differences in T-Cell Responses to Influenza A Virus
Prigge, A. D., Ma, R., Coates, B. M., Singer, B. D., & Ridge, K. M. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0169tr · Cited by 20
Norton, D. L., Ceppe, A., Tune, M. K., McCravy, M. S., Devlin, T., Drummond, M., Carson, S. S., Vincent, B. G., Hagan, R. S., Dang, H., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02595-3 · Cited by 21
Self-citationSang, L., Guo, X., Fan, H., Shi, J., Hou, S., & Lv, Q. (2022) · Cells · doi:10.3390/cells11152322 · Cited by 21
“Additionally, Tregs can resolve fibroproliferation by reducing fibrocytes recruitment depending on blockade of the chemokine (C-X-C motif) ligand 12 (CXCL12)-CXCR4 axis [93].”
BackgroundJiang, Y., Yan, Q., Liu, C., Peng, C.-W., Zheng, W., Zhuang, H., Huang, H.-T., Liu, Q., Liao, H., Zhan, S., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105601 · Cited by 26
“In the late stage of lung injury in mice, AKT inhibitors can promote the recovery of lung injury by increasing the number of regulatory T cells [48], which can inhibit lung fiber proliferation and inflammation [49,50].”
Mutlu, S. M., Scalise, M. C., Philip, S., Gazdhar, A., & Fabian, B. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00945-7 · Cited by 19
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Romero, J. A. A., Chingaté-López, S. M., Camacho, B., Alméciga-Díaz, C. J., & Ramirez-Segura, C. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26423 · Cited by 19
“In murine models, adoptively transferred Tregs alleviated acute lung injury (ALI)-associated fibroproliferation by down-regulating CXCL12 expression [175].”
BackgroundSong, H., Xi, J., Li, G., Xu, S., Wang, C., Cheng, T., Li, H., Zhang, Y., Liu, X., & Bai, J. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-015-1377-3 · Cited by 17
“shown that adoptive transfer of Tregs into intratracheal LPS-challenged Rag-1mice resulted in earlier resolution of inflammation, reduced alveolar proinflammatory cytokines, and limited fibroproliferation [8, 18].”
BackgroundToyama, M., Kudo, D., Aoyagi, T., Miyasaka, T., Ishii, K., Kanno, E., Kaku, M., Kushimoto, S., & Kawakami, K. (2017) · Microbiology and Immunology · doi:10.1111/1348-0421.12564 · Cited by 16
Implications of regulatory T cells in non-lymphoid tissue physiology and pathophysiology
Malko, D., Elmzzahi, T., & Beyer, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954798 · Cited by 16
Jiang, Y., Zhou, M., Cheng, M., Chen, S., & Guo, Y. (2025) · JCI Insight · doi:10.1172/jci.insight.182050 · Cited by 19
“JCI Insight 2025;10(15):e182050 https://doi.org/10.1172/jci.insight.182050 Tregs have been shown to play protective roles in acute and chronic inflammation (11–13) and decrease CAR-T cell–induced CRS (14).”
InfluentialFan, G., Liu, J., Wu, Z. S., Li, C., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049361 · Cited by 26
“In the mouse model, Tregs reduced fibroplasia due to acute lung injury by decreasing fibroblast recruitment (79).”
BackgroundSingle‐Cell Insights Into Macrophage Subtypes in Pulmonary Infections
Lin, Z., Zheng, Y., Zhong, Y., & Wang, H. (2026) · Advanced Science · doi:10.1002/advs.202510758 · Cited by 13
Tai, W., Xu, Y., Ding, J., Wu, H., Du, M., Qu, X., Gao, L., Li, J., & Dong, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485647 · Cited by 17
Gupta, S., Adhikary, S., & Hui, S. P. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13661 · Cited by 13
“At the same time, Tregs act via C- X- C motif chemokine ligand 12 (CXCL12) to prevent the recruitment proliferation of fibrocytes and prevent fibrosis [33].”
BackgroundThe immunoregulatory role of IL‐35 in patients with interstitial lung disease
Osuna‐Gómez, R., Barril, S., Mulet, M., Zamora, C., Millan‐Billi, P., Pardessus, A., Brough, D. E., Sabzevari, H., Semnani, R. T., Castillo, D., et al. (2022) · Immunology · doi:10.1111/imm.13596 · Cited by 13
“However, Tregs can also inhibit pulmonary fibrosis through a variety of mechanisms, such as the inhibition of lung fibroblasts recruitment [13].”
BackgroundT cell subsets in human airways prior to and following endobronchial administration of endotoxin
Ronit, A., Plovsing, R. R., Gaardbo, J. C., Berg, R. M. G., Hartling, H. J., Konge, L., Iversen, M., Ullum, H., Møller, K., & Nielsen, S. D. (2015) · Respirology · doi:10.1111/resp.12497 · Cited by 16
Toward a Paradigm to Distinguish Distinct Functions of FOXP3+ Regulatory T Cells
Weinberg, S. E., & Singer, B. D. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100046 · Cited by 13
Li, G., Cao, Y., Run, Y., Xu, R., & Zheng, Z. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12656 · Cited by 13
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances
Mercurio, V., Cuomo, A., Naranjo, M., & Hassoun, P. M. (2021) · Comprehensive physiology · doi:10.1002/cphy.c200025 · Cited by 17
Regulatory T cells in lung disease and transplantation
Lao, P., Chen, J., Tang, L., Zhang, J., Chen, Y., Fang, Y., & Fan, X. (2023) · Bioscience Reports · doi:10.1042/bsr20231331 · Cited by 12
Li, H., Zhou, R., Wang, C., Li, Y., Zheng, G., Jiang, S., Dong, T., Bai, J., & Xu, S. (2018) · Immunologic Research · doi:10.1007/s12026-018-9014-7 · Cited by 11
Li, Y., Dong, T., Jiang, X., Wang, C., Zhang, Y., Li, Y., Zheng, G., Li, X., Bai, J., & Li, H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.04.033 · Cited by 12
Liu, B., Ding, F., Cao, D., Liu, J., Wang, Y., & Wu, C. F. (2021) · Inflammation Research · doi:10.1007/s00011-021-01483-w · Cited by 11
Peripheral blood fibrocytes: new information to explain the dynamics of Leishmania infection
Silva, R. M. M., dos Santos, C. D. L. P., Diniz, V. Á., de Carvalho, J. J., Guerra, C., & Côrte‐Real, S. (2014) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-0276130247 · Cited by 9
“2012, Garibaldi et al. 2013).”
The emerging role of fibrocytes in ocular disorders
Zhang, F., Liu, K., Zhao, H., & He, Y. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0835-z · Cited by 11
“The pivotal CXCL12/CXCR4 axis in fibrocyte chemotaxis, which is implicated in the recruitment process of fibrocytes, has recently attracted attention [26, 30].”
BackgroundLiu, D., Guo, R., Shi, B., Chen, M., Weng, S., & Weng, J. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1164 · Cited by 9
“26, 27 Recent evidence revealed that excessive lung collagen deposition in lung tissue usually occurred after ALI, even at the onset of ALI, and contributed to lung fibrosis.”
BackgroundFibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease
Loomis-King, H. A., & Moore, B. B. (2013) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x11309010005 · Cited by 9
“Abbreviations AE-IPF acute exacerbation of idiopathic pulmonary fibrosis ALI acute lung injury ASM airway smooth muscle α-SMA alpha smooth muscle actin BM bone marrow DLCO diffusion capacity for carbon monoxide DPLDs diffuse parenchymal lung diseases ECM extracellular matrix ELISA enzyme linked immunosorbent assay EMT…”
BackgroundStepwise acquisition of unique epigenetic signatures during differentiation of tissue Treg cells
Braband, K. L., Kaufmann, T., Floess, S., Zou, M., Huehn, J., & Delacher, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1082055 · Cited by 12
“This population is required for preventing severe acute lung damage in an influenza A virus (IAV) infection model (26, 27), and promotes tissue repair after acute lung injury in mice (28–30), supporting lung epithelial proliferation (31) and reducing fibroproliferation (32).”
BackgroundFeuerer, M., Gray, D. H. D., Rankin, L. C., Schmidleithner, L., & Liston, A. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082924-092651 · Cited by 10
Xie, Y., Yi, Q., Xu, C., Wang, Y., Jiang, Y., Feng, Y., Wang, L., Yang, H., Zhang, Y., & Wang, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04313-6 · Cited by 9
“Previous reports have proven that the CXCL12/CXCR4 axis is crucial in IPF, with CXCR4 + fibroblasts being recruited to the lungs of IPF patients, while Tregs have been found to reduce the expression of CXCL12, thus potentially playing a key role in reducing the recruitment of fibroblasts [26].”
Umbilical Cord Blood Cells Do Not Reduce Ventilation-Induced Lung Injury in Preterm Lambs
Smith, M. J., Chan, K. Y. Y., Papagianis, P. C., Nitsos, I., Zahra, V. A., Allison, B. J., Polglase, G. R., & McDonald, C. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00119 · Cited by 7
Magnusson, J. M., Bobbio, E., Danielsson, C., Wallinder, A., Dellgren, G., & Bollano, E. (2022) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.11.031 · Cited by 7
Hu, J., Ge, S., Sun, B., Ren, J., Xie, J., & Zhu, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.895629 · Cited by 7
Kass, D. J., Flynn, M., & Baker, E. (2015) · Current Biomarker Findings · doi:10.2147/cbf.s81362 · Cited by 7
“98 102 Markedly decreased expression of CD28, a necessary component of T-cell activation, on the surface of CD4 + T-cells was correlated with a more severe 1-year outcome in IPF.”
Misra, R. S. (2014) · PubMed · Cited by 6
Liang, T., Lu, L., Tang, S.-Y., Zheng, Z., Shi, K., & Liu, J. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i4.150 · Cited by 5
Role of regulatory T cells in mouse lung development
Jiang, J.-F., Lu, H., Wang, M., He, L., Zhu, Y., & Qiao, Y. (2024) · Experimental Biology and Medicine · doi:10.3389/ebm.2024.10040 · Cited by 5
Halter, S., Rosenzwajg, M., Klatzmann, D., Sitbon, A., & Monsel, A. (2024) · Anesthesiology · doi:10.1097/aln.0000000000005047 · Cited by 7
“36 In addition, Tregs are involved in the adenosine signaling pathway, which plays a key role in the resolution of ARDS.”
Role of Immune Cells in the Initiation and Progression of Pulmonary Fibrosis
Soumyakrishnan, S., Ayariga, J. A., Sreepriya, M., & Sudhandiran, G. (2022) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2023047301 · Cited by 5
Zhao, H. Z., Wang, L., Yan, Y., Zhao, Q.-H., He, J., Jiang, R., Luo, C., Qiu, H., Miao, Y., Gong, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1197752 · Cited by 5
“Tregs can attenuate fiber recruitment and PF by inhibiting the CXC chemokine ligand (CXCL)12 (46).”
BackgroundRole of CXCL12/CXCR4-Mediated Circulating Fibrocytes in Pulmonary Fibrosis
Xie, L., & Zhao, L. (2017) · Journal of Biomedicine · doi:10.7150/jbm.18949 · Cited by 5
Elucidating the pathogenesis of oral submucous fibrosis: A comprehensive review
Sharma, D., Pal, S., Pal, U. S., & Yadav, N. P. (2025) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2025.106362 · Cited by 9
The relationship between regulatory T cells and radiation therapy
Hou, P.-F., Zhu, L., Pan, Y., Sun, X., & Pu, J. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2019.07.160 · Cited by 4
Zemans, R. L., & Downey, G. P. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00015-4 · Cited by 4
Macrophages and Pulmonary Fibrosis
Chen, S., Song, X., & Lv, C. (2025) · Current Molecular Medicine · doi:10.2174/0115665240286046240112112310 · Cited by 4
Pericytes and T Cells in Lung Injury and Fibroproliferation
Birbrair, A., Prazeres, P. H. D. M., Files, D. C., & Delbono, O. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_7 · Cited by 4
Self-citationDevelopment of Adaptive Immunity and Its Role in Lung Remodeling
Esnault, S. J., & Jarjour, N. N. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-32259-4_14 · Cited by 4
Bian, L., Mao, L., Bi, Y., Zhou, S., Chen, Z., Wen, J., Jin, S. K., & Wang, L. (2017) · Apmis · doi:10.1111/apm.12748 · Cited by 3
Singer, B. D., & D’Alessio, F. R. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3399-0 · Cited by 3
Self-citationWei, J., Nai, G. Y., Wu, M., Huang, Y. M., Gan, Z. P., Wei, Z. B., Li, H., Zhou, W. J., & Liu, R. R. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2588840 · Cited by 2
“However, Singer BD proposed a different perspective, suggesting that CD25 + Foxp3+ Tregs could protect against lung injury and promote lung injury repair, as observed in previous studies [25–27].”
Morey, M. G., Illanad, G. H., & Rasool, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1754620 · Cited by 3
Ischemic Brain Injury and Regulatory T Cells
Ito, M., Srirat, T., Nakamura, T., Komai, K., & Yoshimura, A. (2019) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1901023 · Cited by 2
Qianqian, Z., Mei, G., Min, Y., Qingfeng, Z., Xiufen, X., Zejun, F., Yahong, L., & Mingwei, Y. (2023) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207326666230718154641 · Cited by 2
A conserved immune trajectory of recovery in hospitalized COVID-19 patientsPreprint
Burnett, C. E., Okholm, T. L. H., Tenvooren, I., Marquez, D. M., Tamaki, S. J., Sandoval, P. M., Calfee, C. S., Hendrickson, C. M., Kangelaris, K. N., Langelier, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.15.484467 · Cited by 2
“Interestingly, CD4 Tregs, which are known to play a role in ARDS resolution and pulmonary recovery, demonstrate a gradual increase in frequency during patient intubation followed by the steepest increase after extubation (Mock et al. 2014; Garibaldi et al. 2013) (Figure S6E).”
BackgroundResultT Regulatory Mechanisms in Airway and Interstitial Lung Disease
Pastore, C., Stadler, B. D., Sperling, A. I., & Velez, T. E. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2703-4491 · Cited by 3
CXCL11 levels regulate lung Treg responses to deter the onset of HIV-related COPD
Dabo, A. J., Geraghty, P. M., Evgrafov, O. V., Campos, M., Hadas, E., Kim, B.-H., Potash, M. J., Volsky, D. J., & Foronjy, R. (2026) · Respiratory Research · doi:10.1186/s12931-026-03495-8 · Cited by 1
Molecular Systems Architecture of Fibrotic Lung Microenvironment in Idiopathic Pulmonary Fibrosis
Ayyadurai, V. A. S., Manoharan, Y., & Deonikar, P. (2026) · Cells · doi:10.3390/cells15151364 · Cited by 1
“Fibrocytes comprise ~20% of IPF myofibroblasts, with elevated levels in blood and BALF signaling disease exacerbation [79].”
4.4 Adaptive Immune Responses to Biomaterials ☆
Love, R. J., & Jones, K. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10181-x · Cited by 1
Role of Platelet-Mediated Cytoadherence and Chemokines Release in Severe Malaria
Srivastava, K. (2015) · SOJ Immunology · doi:10.15226/soji/3/3/00132 · Cited by 1
“In recent years, the role of T-cells in the pathogenesis of non-malaria related ALI has also been explained [32,33].”
BackgroundRipple, M. J., Huang, M., Stephenson, S. T., Mohammad, A. F., Tidwell, M., Fitzpatrick, A. M., Kamaleswaran, R., & Grunwell, J. R. (2023) · Critical Care Explorations · doi:10.1097/cce.0000000000000935 · Cited by 1
Braband, K. L., Kaufmann, T., Beumer, N., Simon, M., Helbich, S. S., Mihoc, D. M., Voss, M. M., Nedwed, A. S., Bauer, K., Mallm, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.14.653926 · Cited by 1
Potential Mechanistic Links Between Aging and IPF
Pan, H., Gulati, M., & Herzog, E. L. (2015) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814635011_0016
Cronicon OPEN ACCESS MICROBIOLOGY Review Article
Ayuba, A., Abbas, M. A., Islam, A., Das, D., & Nepal, A. (2016)
Epiphânio, S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2019.tde-08102019-162802
Brasile, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819451-5.00005-6
Mäkelä, K. (2021) · Työväentutkimus Vuosikirja
Molecular Genetic Factors in Prediction of the Risk of Chronic Obstructive Pulmonary Disease
Хотько, Е. А., & Таганович, А. Д. (2021) · Лабораторная диагностика Восточная Европа · doi:10.34883/pi.2021.10.2.005
Chen, J., Zhang, X., Xie, J., Xue, M., Liu, L., Yang, Y., & Qiu, H. (2020) · Figshare · doi:10.6084/m9.figshare.12695489
Zhang, S., Fu, Q., Xu, Z., Fu, M., Zhao, J., & Yu, W. (2025) · Hereditas · doi:10.1186/s41065-025-00480-x
Beyond suppression: Treg specialization in infection and tissue repair
Hilaire, M., & Joller, N. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.11.005
Norton, D. L., Ceppe, A., Tune, M. K., McCravy, M. S., Devlin, T., Drummond, M. B., Carson, S. S., Vincent, B. G., Hagan, R. S., Dang, H., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13225807
Self-citationChen, J., Zhang, X., Xie, J., Xue, M., Liu, L., Yang, Y., & Qiu, H. P. (2020) · Figshare · doi:10.6084/m9.figshare.12695486
Chen, J., Zhang, X., Xie, J., Xue, M., Liu, L., Yang, Y., & Qiu, H. (2020) · Figshare · doi:10.6084/m9.figshare.12695483
CNS1-dependent regulatory T cells shape recovery from acute lung injury
Mccullough, M., Tune, M. K., Griffith, J. W., Banten, B. L., He, M., Feng, Y., Vincent, B. G., Milner, J. J., Tsagaratou, A., Wan, Y. Y., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag119
Self-citationElevated ST2+ Tregs in RA-ILD: correlation with pulmonary fibrosis and the IL-33/ST2/AREG axis
Zhang, P., Wang, J., Sun, H., Miao, J., & Zheng, Z. (2026) · Arthritis Research & Therapy · doi:10.1186/s13075-026-03836-4
“For instance, lung Tregs respond to pulmonary inflammatory signals through two distinct axes: the CCR4-CCL17/CCL20 and the CCR6-CCL17/CCL20 axes, thereby recruiting Tregs to suppress allergic asthma, while migrating to fibrotic lung tissue via the CXCR3-CXCL9/10 axis [38].”
Adaptive Immune Responses to Biomaterials
Buuren, M. N. V., Fitzpatrick, L. E., Love, R. J., & Jones, K. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30151-3.00015-2
Metadata
- Authors
- Garibaldi, B. T., D’Alessio, F. R., Mock, J. R., Files, D. C., Chau, E., Eto, Y., Drummond, M. B., Aggarwal, N. R., Sidhaye, V., & King, L. S.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Garibaldi, Brian T.
- ORCID
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-01
- Volume
- 48
- Issue
- 1
- Pages
- 35-43
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC3547087
- OpenAlex
- W2151856750
- Cited by
- 182
- References
- 49
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 8 · 2023: 10 · 2022: 18 · 2021: 20 · 2020: 22 · 2019: 11 · 2018: 11 · 2017: 16 · 2016: 13 · 2015: 9 · 2014: 17 · 2013: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johns Hopkins University
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL089346, F32HL104908, F32HL110561, K99HL103973)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- acute lung injury, regulatory T cells, fibroproliferation, CXCL12, CXCR4, AMD3100, collagen deposition, pulmonary fibrosis, lipopolysaccharide-induced lung injury, adoptive Treg transfer
- MeSH terms
- Cyclams, Animals, Benzylamines, Fibroblasts, Heterocyclic Compounds, Lipopolysaccharides, Mice, Inbred C57BL, Signal Transduction, Mice, Knockout, Homeodomain Proteins, Adoptive Transfer, Receptors, CXCR4, Cell Proliferation, T-Lymphocytes, Regulatory, Mice, Chemokine CXCL12, Acute Lung Injury, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.